http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008189937-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1af8df51ce24ca931ae718fb747f6aa0
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G03G5-0661
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G03G5-047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G03G5-0696
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G03G5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G03G5-047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09B47-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09B67-48
filingDate 2008-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f600d8299be71417f88b272d29a9bb2
publicationDate 2008-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2008189937-A
titleOfInvention Crystals of porphyrinato zinc compounds
abstract PROBLEM TO BE SOLVED: To provide a crystal of a novel crystal form of 5,10,15,20-tetra (4-pyridyl) -21H, 23H-porphyrin zinc compound. 5,10,15,20-tetrapyridyl-21H, 23H-porphyrinato having one crystal form selected from the group consisting of the following (a), (b) and (c) Crystal of zinc compound. (A) Crystal form having peaks at 9.4 °, 14.2 ° and 22.2 ° of the Bragg angle (2θ ± 0.2 °) in CuKα characteristic X-ray diffraction (b) Bragg in CuKα characteristic X-ray diffraction Crystal form having peaks at 7.0 °, 10.5 °, 17.8 ° and 22.4 ° of angle (2θ ± 0.2 °) (c) Bragg angle (2θ ± 0) in CuKα characteristic X-ray diffraction .2 °) crystal forms with peaks at 7.4 °, 10.2 ° and 18.3 ° [selection] None
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016027379-A
priorityDate 2001-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H05275771-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0954450-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002371202-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H10223372-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123047
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419545382
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8020
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448481472
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457630696
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420319568
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415745606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457493197
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13389
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419574667
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70612328
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448620780
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19742742
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70186

Total number of triples: 37.